CNBC |
Novo Nordisk's oral diabetes drug beats Jardiance in study
CNBC Novo Nordisk's experimental diabetes pill proved better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim's established Jardiance. Novo hopes to launch the once-daily pill in 2020. The pill would simulate insulin production as part ... |
from diabetes - Google News
Social Plugin